The DOI matches its Crossref record; 428 of the 428 references it cites were found in a registry or an index.
Molecular genetics of prostate cancer: new prospects for old challenges
Open accessAbstract
Despite much recent progress, prostate cancer continues to represent a major cause of cancer-related mortality and morbidity in men. Since early studies on the role of the androgen receptor that led to the advent of androgen deprivation therapy in the 1940s, there has long been intensive interest in the basic mechanisms underlying prostate cancer initiation and progression, as well as the potential to target these processes for therapeutic intervention. Here, we present an overview of major themes in prostate cancer research, focusing on current knowledge of principal events in cancer initiation and progression. We discuss recent advances, including new insights into the mechanisms of castration resistance, identification of stem cells and tumor-initiating cells, and development of mouse models for preclinical evaluation of novel therapuetics. Overall, we highlight the tremendous research progress made in recent years, and underscore the challenges that lie ahead.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–428 of 428
Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy
Blum, D. L., Koyama, T., M’Koma, A. E., Iturregui, J. M., Martínez‐Ferrer, M., Uwamariya, C., Smith, J. A. J., Clark, P. E., & Bhowmick, N. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1716 · Cited by 67
Lee, S., Poulogiannis, G., Pyne, S., Jia, S., Zou, L., Signoretti, S., Loda, M. F., Cantley, L. C., & Roberts, T. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005642107 · Cited by 67
Zhang, Y., Zhang, J., Lin, Y., Lan, Y., Lin, C., Xuan, J. W., Shen, M. M., McKeehan, W. L., Greenberg, N. M., & Wang, F. (2008) · Development · doi:10.1242/dev.009910 · Cited by 66
Self-citationRNASEL Gene Polymorphisms and the Risk of Prostate Cancer: a Meta-analysis
Li, H., & Tai, B. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2799 · Cited by 63
Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer†
Swalwell, J. I., Vocke, C. D., Yang, Y., Walker, J. R., Grouse, L., Myers, S. H., Gillespie, J. W., Bostwick, D. G., Duray, P. H., Linehan, W. M., et al. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10015 · Cited by 60
Foster, B. A., Evangelou, A. I., Kaplan, P. J., DeMayo, F. J., Greenberg, N. M., & Gingrich, J. R. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700915.x · Cited by 54
p18Ink4c and Pten Constrain a Positive Regulatory Loop between Cell Growth and Cell Cycle Control
Bai, F., Pei, X., Pandolfi, P. P., & Xiong, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00266-06 · Cited by 53
Joshua, A. M., Vukovic, B., Braudey, I., Hussein, S., Zieleńska, M., Srigleyb, J., Evans, A. J., & Squire, J. A. (2007) · Neoplasia · doi:10.1593/neo.06745 · Cited by 51
Commentary on Essential roles of PI(3)K-p110β in cell growth, metabolism, and tumorigenesis
Huang, H. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.12.002 · Cited by 50
Models of metastatic prostate cancer: a transgenic perspective
Winter, S. F., Cooper, A., & Greenberg, N. M. (2003) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500655 · Cited by 50
BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma
Jeong, J. H., Wang, Z., Guimarães, A. R., Ouyang, X., de Figueiredo, J. L., Ding, Z., Jiang, S., Guney, I., Kang, G. H., Shin, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003949 · Cited by 49
Self-citationThe polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells
Bryant, R. J., Winder, S. J., Cross, S. S., Hamdy, F. C., & Cunliffe, V. T. (2007) · The Prostate · doi:10.1002/pros.20705 · Cited by 47
Hill, K. M., Kalifa, S., Das, J., Bhatti, T., Gay, M. D., Williams, D., Taliferro-Smith, L., & Marzo, A. D. D. (2010) · The Prostate · doi:10.1002/pros.21108 · Cited by 47
Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome
Xu, J., Meyers, D. A., Freije, D., Isaacs, S. D., Wiley, K. E., Nusskern, D. R., Ewing, C. M., Wilkens, E. P., Bujnovszky, P., Bova, G. S., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61689-6 · Cited by 46
Stem cells: The root of prostate cancer?
Kasper, S. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21489 · Cited by 46
Foster, C. S., Dodson, A. R., Karavana, V. N., et al. (2002) · The Journal of Pathology · doi:10.1002/path.1194 · Cited by 44
Gelmann, E. P., Steadman, D. J., Ma, J., Ahronovitz, N., Voeller, H. J., Swope, S. L., Abbaszadegan, M. R., Brown, K. M., Strand, K., Hayes, R. B., et al. (2002) · PubMed · Cited by 43
Gene expression profiling in the developing prostate
Pritchard, C. C., & Nelson, P. S. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00274.x · Cited by 43
Muhlbradt, E., Asatiani, E., Ortner, E., Wang, A., & Gelmann, E. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3022 · Cited by 37
Nelson, W. G. (2007) · Current Opinion in Urology · doi:10.1097/mou.0b013e3280eb110f · Cited by 32
Androgen-Independent Prostate Cancer
Schrijvers, D. L. A. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-40901-4_14 · Cited by 31
A year of successful cancer vaccines points to a path forward.
Morse, M. A., & Whelan, M. (2010) · PubMed · Cited by 23
Dicer Ablation Impairs Prostate Stem Cell Activity and Causes Prostate Atrophy
Zhang, L., Zhang, B., Valdez, J. M., Wang, F., Ittmann, M., & Xin, L. (2010) · Stem Cells · doi:10.1002/stem.455 · Cited by 21
A Probasin‐MerCreMer BAC allows inducible recombination in the mouse prostate
Birbach, A., Casanova, E., & Schmid, J. A. (2009) · genesis · doi:10.1002/dvg.20558 · Cited by 18
Gene Targeting to the Stroma of the Prostate and Bone
Jackson, R. S., Franco, O. E., & Bhowmick, N. A. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00273.x · Cited by 16
Robzyk, K., Oen, H. O., Buchanan, G., Butler, L. M., Tilley, W. D., Mandal, A. K., Rosen, N. X., & Caplan, A. J. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.01.016 · Cited by 16
Temporally controlled prostate epithelium‐specific gene alterations
Luchman, H. A., Friedman, H. C., Villemaire, M. L., Peterson, A. C., & Jirik, F. R. (2008) · genesis · doi:10.1002/dvg.20386 · Cited by 15
Searching for the gatekeeper oncogene of prostate cancer
Gelmann, E. P. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(03)00060-x · Cited by 11
Cited by
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Punctuated Evolution of Prostate Cancer Genomes
Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,320
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022) · Molecules · doi:10.3390/molecules27175730 · Cited by 904
Genetics and biology of prostate cancer
Wang, G., Zhao, D., Spring, D. J., & DePinho, R. A. (2018) · Genes & Development · doi:10.1101/gad.315739.118 · Cited by 750
Metadata
- Authors
- Shen, M. M., & Abate-Shen, C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-09-15
- Volume
- 24
- Issue
- 18
- Pages
- 1967-2000
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2148416479
- Cited by
- 946
- References
- 428
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.